参考文献/References:
[1] Lontchi-Yimagou E，Sobngwi E，Matsha TE，et al.Diabetes mellitus and inflammation[J].Curr Diab Rep，2013，13 （3）：435-444.
[2] Chen C，Zhang Y，Huang C.Berberine inhibits PTP1B activity and mimics insulin action[J].Biochem Biophys Res Commun，2010，397 （3）：543-547.
[3] Yang J，Yin J，Gao H，et al.Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients[J].Evid Based Complement Alternat Med，2012，2012：363845.
[4] 范梅琳，刘云峰，章毅，等.二甲双胍对脂多糖诱导的THP-1细胞相关炎症因子及凋亡的影响[J].中华内分泌代谢杂志，2013，29（9）：801-803.
[5] Sell H，Habich C，Eckel J.Adaptive immunity in obesity and insulin resistance [J].Nat Rev Endocrinol，2012，8：709-716.
[6] Kanter JE，Bornfeldt KE. Inflammation and diabetes-accelerated atherosclerosis：myeloid cell mediators[J].Trends Endocrinol Metab，2013，24（3）：137-144.
[7] Luotola K， Pietil?覿 A，Zeller T，et al.Associations between inter-leukin-1 （IL-1） gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes[J].Intern Med，2011，269（3）： 322-332.
[8] Vozarova B，Weyer C，Hanson K，et al.Circulating interleukin-6 in relation to adiposity，insulin action，and insulin secretion[J].Obes Res，2001，9（7）：414-417.
[9] Pradhan AD，Manson JE，Rifai N，et al.C-reactive protein，inter-leukin-6，and risk of developing type 2 diabetes mellitus [J].JAMA，2001，286（3）：327-334.
[10] Ye J，McGuinness OP.Inflammation during obesity is not all bad：Evidence from animal and human studies[J].Physiol Endocrinol Metab，2013，304（5）：E466-E477.
[11] Van Sickle BJ，Simmons J，Hall R，et al.Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus.[J].Cytokine，2009，48（3）：290-294.
[12] Koskela UE，Kuusisto SM，Nissinen AE，et al High vitreous concentration of IL-6 and IL-8，but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy [J].Ophthalmic Res，2013，49 （2）：108-114.
[13] Fasshauer M，Paschke R.Regulation of adipocytokines and insulinresistance[J].Diabetologia，2003，46（12）：1594-1603.
[14] Ruan H，Miles PD，Ladd CM，et al.Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha：implications for insulin resistance[J].Diabetes，2002，51（11）：3176-3188.
[15] Meng S，Wang LS，Huang ZQ，et al.Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention[J].Clin Exp Pharmacol Physiol，2012，39（5）：406-411.
相似文献/References:
[1]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]